A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative ImmunogenicityMatthew D. J. Dicks, Matthew G. Cottingham, Kalifa Bojang et al.|PLoS ONE|2012Cited by 398
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technologyYuanyuan Li, Sumi Biswas, Darren B. Leneghan et al.|Scientific Reports|2016Cited by 99
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in miceGeorge M. Warimwe, Sarah C. Gilbert, Gema Lorenzo et al.|Virology Journal|2013Cited by 60
Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1Sumi Biswas, Simon J. Draper, Matthew D. J. Dicks et al.|PLoS ONE|2011Cited by 50
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in miceMatthew D. J. Dicks, Matthew G. Cottingham, Alexandra J. Spencer et al.|Scientific Reports|2015Cited by 44